We are live on ! Find out more
AAP

Ardsley Advisory Partners Portfolio holdings

AUM $960M
1-Year Est. Return 207.76%
This Fund
S&P 500
This Quarter Est. Return
-4.22%
1 Year Est. Return
+207.76%
3 Year Est. Return
+554.53%
5 Year Est. Return
+728.66%
10 Year Est. Return
+4,084.52%
AUM
$525M
AUM Growth
-$131M
Cap. Flow
-$97.6M
Cap. Flow %
-18.61%
Top 10 Hldgs %
43.8%
Holding
176
New
50
Increased
27
Reduced
23
Closed
70

Sector Composition

Rank Sector Weight
1 Technology 38.41%
2 Healthcare 10.21%
3 Utilities 6.74%
4 Industrials 6.26%
5 Consumer Staples 5.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CTLP
1
DELISTED
Cantaloupe
CTLP
$44.5M 8.48%
5,008,000
+35,000
+0.7% +$348K
TBT icon
2
CALL
ProShares Trust UltraShort Lehman 20+ Year Treasury
TBT
$289M
$33.8M 6.44%
2,000,000
-400,000
-17% -$6.94M
STKL
3
DELISTED
SunOpta
STKL
$28.3M 5.39%
4,066,100
+855,100
+27% +$6.19M
AZN icon
4
CALL
AstraZeneca
AZN
$267B
$23.3M 4.44%
200,000
-50,000
-20% -$5.88M
DT icon
5
Dynatrace
DT
$12.7B
$20.3M 3.87%
336,000
-109,000
-24% -$7.43M
SGRY icon
6
Surgery Partners
SGRY
$2.04B
$18.2M 3.46%
340,000
+40,000
+13% +$1.86M
FTAI icon
7
CALL
FTAI Aviation
FTAI
$21.8B
$17.2M 3.28%
696,745
-292,750
-30% -$6.4M
HZNP
8
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$15.1M 2.88%
140,000
-136,000
-49% -$14.8M
AMPS
9
DELISTED
Altus Power
AMPS
$14.7M 2.79%
+1,402,500
New +$14.2M
SDIG
10
DELISTED
Stronghold Digital Mining, Inc. Class A Common Stock
SDIG
$14.6M 2.78%
+113,669
New +$23.8M
VST icon
11
Vistra
VST
$50.1B
$13.7M 2.61%
602,500
+99,500
+20% +$2M
MBII
12
DELISTED
Marrone Bio Innovations, Inc.
MBII
$13.2M 2.52%
18,335,767
+1,643,014
+10% +$1.33M
HLIT icon
13
Harmonic Inc
HLIT
$1.2B
$12.3M 2.34%
1,043,000
+73,000
+8% +$752K
GSM icon
14
FerroAtlántica
GSM
$628M
$11.8M 2.25%
1,899,000
+123,000
+7% +$841K
FTAI icon
15
FTAI Aviation
FTAI
$21.8B
$11.7M 2.22%
471,913
-301,533
-39% -$6.59M
THC icon
16
Tenet Healthcare
THC
$22.6B
$10.6M 2.02%
130,000
+75,000
+136% +$5.48M
XBI icon
17
State Street SPDR S&P Biotech ETF
XBI
$10.1B
$10.1M 1.92%
+90,000
New +$10.9M
RUN icon
18
Sunrun
RUN
$2.3B
$9.96M 1.9%
290,500
+5,500
+2% +$257K
JAMF
19
DELISTED
Jamf
JAMF
$9.69M 1.85%
+255,000
New +$9.87M
ALT icon
20
Altimmune
ALT
$581M
$9.65M 1.84%
1,054,000
+26,500
+3% +$282K
COUP
21
DELISTED
Coupa Software Incorporated
COUP
$9.54M 1.82%
+60,350
New +$12.4M
S icon
22
SentinelOne
S
$6.29B
$9.47M 1.8%
+187,500
New +$11M
GPN icon
23
Global Payments
GPN
$23.9B
$7.71M 1.47%
+57,000
New +$7.86M
STKL
24
CALL
DELISTED
SunOpta
STKL
$7.64M 1.46%
1,100,000
+600,000
+120% +$4.34M
ADTN icon
25
Adtran
ADTN
$730M
$7.64M 1.46%
+334,750
New +$6.77M

Similar funds

Ardsley Advisory Partners's Q4 2021 Portfolio in Review

As of Q4 2021, Ardsley Advisory Partners held 176 positions worth $525M, down 20% from $656M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Ardsley Advisory Partners withdrew a net $97.6M in Q4 2021, closing 70 positions and reducing 23 holdings. Its most notable exit was FIVE9, an estimated $12M position sold in full.

By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 28% a quarter earlier, followed by Healthcare and Utilities.

Against the trend, Ardsley Advisory Partners opened a new position in Stronghold Digital Mining, Inc. Class A Common Stock worth $14.6M.

  • Ardsley Advisory Partners's largest Q4 2021 buy was Stronghold Digital Mining, Inc. Class A Common Stock: 113,669 shares worth $14.6M.
  • Ardsley Advisory Partners added most to ZENDESK INC in Q4 2021, an estimated $6.54M increase.
  • Ardsley Advisory Partners's biggest Q4 2021 reduction was AstraZeneca, cutting an estimated $17.7M.
  • Ardsley Advisory Partners fully exited FIVE9 in Q4 2021, selling an estimated $12M.
  • Ardsley Advisory Partners's ten largest holdings make up 44% of its $525M portfolio in Q4 2021.
  • Ardsley Advisory Partners opened 50 new positions and closed 70 in Q4 2021.
  • Ardsley Advisory Partners's portfolio value fell 20% quarter-over-quarter to $525M.

Based on Ardsley Advisory Partners's 13F filing for Q4 2021, filed 14 Feb 2022.